Here’s what you should know:
1. The company will aim to create emerging market-facing global endoscopy solutions.
2. The company is targeting the flexible endoscopy market for its growth potential. In a release, the company claims the market is currently valued at $2.5 billion, growing at a compound annual growth rate of 5 percent.
3. The company will be headquartered in Asia and will distribute products in Asia, Latin America, Eastern Europe, the Middle East and Africa.
More articles on gastroenterology:
Effector, Pfizer, Merck partner to test novel immuno-oncology agents in CRC — 4 key notes
GI center to know: Gastroenterology Consultants of Southwest Virginia
Sucampo Pharmaceuticals aims to grow Amitiza line — 4 key notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
